Drug profile · INN
carvedilol phosphate
COREG CR
- US status
- approved
- Patents linked
- 2
- News articles
- 0
Quick answer
carvedilol phosphate (COREG CR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN carvedilol phosphate
Brand COREG CR
Route ORAL
Formulation CAPSULE, EXTENDED RELEASE
Related patents
Search patents →Frequently asked questions
What is carvedilol phosphate?
carvedilol phosphate (COREG CR) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for carvedilol phosphate?
COREG CR is a marketed brand name for carvedilol phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carvedilol phosphate?
carvedilol phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.